Proximity Labeling and Genetic Screening Reveal that DSG2 is a Counter Receptor of Siglec‐9 and Suppresses Macrophage Phagocytosis
Abstract Cancer cells present sialylated glycoconjugates that modulate the activity of various immune cells within the tumor microenvironment through trans interaction with immunosuppressive Siglec receptors. Identifying counter receptors for Siglecs can provide valuable targets for cancer immunothe...
Saved in:
| Main Authors: | Ying Wu, Yuyu You, Tingsong Jiang, Yuqi He, Qingchi Fan, Xinlei Zeng, Ting Li, Yuxing Lu, Liang Qi, Fengxia Zhou, Lingyu Sun, Danyang Wang, Yong Zou, Guigen Zhang, Yanqiu Yuan, Yang Mao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-03-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202406654 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phosphoproteomics identifies microglial Siglec‐F inflammatory response during neurodegeneration
by: Nader Morshed, et al.
Published: (2020-12-01) -
Comprehensive Modular Synthesis of Ganglioside Glycans and Evaluation of their Binding Affinities to Siglec‐7 and Siglec‐9
by: Avijit K. Adak, et al.
Published: (2025-01-01) -
Influence of vacuum carburizing treatment on fatigue crack growth characteristic in DSG2
by: K. Nambu, et al.
Published: (2015-10-01) -
Siglecs-mediated immune regulation in neurological disorders
by: Huifang Tu, et al.
Published: (2024-12-01) -
<i>DSG4</i> Gene Variants as a Cause of Hypotrichosis in the Child with Severe Atopic Dermatitis: Clinical Case
by: Nikolay N. Murashkin, et al.
Published: (2023-11-01)